Japan OKs Bill to Impose Levies on Falsified Drug Ads
Newsfrom JapanPolitics Lifestyle
Tokyo, Nov. 27 (Jiji Press)--Japan on Wednesday enacted a bill to impose levies on drug makers and other firms using falsified or extravagant advertisements for selling pharmaceutical products.
The House of Councillors, the upper chamber of the Diet, the country's parliament, approved the bill to amend the pharmaceuticals and medical devices law at a plenary session.
Under the revised law, violating firms will be slapped with a surcharge worth 4.5 pct of their sales achieved during the period they put such misleading ads. Those who voluntarily report their violations will be imposed with a half of the original surcharge.
The new rule was introduced in the wake of clinical trial data manipulations linked to the hypertension drug Diovan by Novartis Pharma K.K., a Japanese unit of Swiss drug giant Novartis AG.
The revised law will also pave the way for the provision of online instructions by pharmacists on the use of drugs. Face-to-face guidance was obligatory in principle before the amendment.
[Copyright The Jiji Press, Ltd.]